Author:
Chen Wenkang,Wang Wuping,Zhao Zhengping,Wen Zhenyu,Li Yingqi,Ge Zhenjian,Lai Yongqing,Ni Liangchao
Abstract
BackgroundRenal cell carcinoma (RCC) stands as the most prevalent form of urogenital cancer. However, there is currently no universally accepted method for predicting the prognosis of RCC. MiRNA holds great potential as a prognostic biomarker for RCC.MethodsA total of 100 cases with complete paraffin specimens and over 5-year follow-up data meeting the requirements were collected. Utilizing the clinical information and follow-up data of the specimens, an information model was developed. The expression levels of eight microRNAs were identified using RT-qPCR. Finally, determine and analyze the clinical application value of these microRNAs as prognostic markers for RCC.ResultsSignificant differences were observed in the expression of two types of miRNAs (miR-378a-5p, miR-23a-5p) in RCC tissue, and three types of miRNAs (miR-378a-5p, miR-642a-5p, miR-23a-5p) were found to be linked to the prognosis of RCC. Establish biomarker combinations of miR-378a-5p, miR-642a-5p, and miR-23a-5p to evaluate RCC prognosis.ConclusionThe combination of three microRNA groups (miR-378a-5p, miR-642a-5p, and miR-23a-5p) identified in paraffin section specimens of RCC in this study holds significant potential as biomarkers for assessing RCC prognosis.
Reference32 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021
2. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours;Moch;Eur Urol,2016
3. Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment;Bahadoram;G Ital Nefrol,2022
4. Renal cell carcinoma: Review of etiology, pathophysiology and risk factors;Petejova;BioMed Pap Med Fac Univ Palacky Olomouc Czech Repub,2016
5. Contemporary management of advanced renal cell carcinoma;Khanna;Clin Adv Hematol Oncol,2018